WuXi Biologics (Cayman) Inc
HKEX:2269
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
E
|
Eagle Plains Resources Ltd
F:33E
|
CA |
|
I
|
Icade SA
OTC:CDMGF
|
FR |
|
V
|
Verbund AG
VSE:VER
|
AT |
|
Addtech AB
F:AZZ2
|
SE |
|
Cybertech Systems and Software Ltd
NSE:CYBERTECH
|
IN |
|
N
|
Nippon Yusen KK
OTC:NPNYY
|
JP |
|
S
|
Spectral Medical Inc
OTC:EDTXF
|
CA |
|
A
|
Aramis Group SAS
F:6T6
|
FR |
|
A
|
AGS Transact Technologies Ltd
NSE:AGSTRA
|
IN |
|
C
|
Consolidated Edison Inc
LSE:0I35
|
US |
|
P
|
Puregold Price Club Inc
XPHS:PGOLD
|
PH |
Wall St Price Targets
Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 45.74 HKD with a low forecast of 30.3 HKD and a high forecast of 81.63 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
45.74
HKD
According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 45.74 HKD with a low forecast of 30.3 HKD and a high forecast of 81.63 HKD.
What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%
Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
18%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%
Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.
